Lantern Pharma Q2 EPS $(0.40) Beats $(0.48) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.48) by 17.53 percent. This is a 13.04 percent increase over losses of $(0.46) per share from
Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.48) by 17.53 percent. This is a 13.04 percent increase over losses of $(0.46) per share from the same period last year.